| # | Drug | Count |
|---|---|---|
| 0 | EPOETIN ALFA | 5 |
| 1 | LANTHANUM CARBONATE | 4 |
| 2 | DALFAMPRIDINE | 2 |
| 3 | ECULIZUMAB | 2 |
| 4 | ERYTHROPOIETIN | 2 |
| 5 | FUROSEMIDE | 2 |
| 6 | GLATIRAMER ACETATE | 2 |
| 7 | MYCOPHENOLIC ACID | 2 |
| 8 | TACROLIMUS | 2 |
| 9 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SEVELAMER HYDROCHLORIDE | 1 | 0.0017 |
| 1 | LANTHANUM CARBONATE | 4 | 0.0008 |
| 2 | EPOETIN ALFA | 5 | 0.0004 |
| 3 | GLUCAGON | 1 | 0.0002 |
| 4 | NORGESTIMATE AND ETHINYL ESTRADIOL | 1 | 0.0002 |
| 5 | CILOSTAZOL | 1 | 0.0002 |
| 6 | VANCOMYCIN HYDROCHLORIDE | 1 | 0.0001 |
| 7 | IRON SUCROSE | 1 | 0.0001 |
| 8 | ERYTHROPOIETIN | 2 | 0.0001 |
| 9 | SEVELAMER CARBONATE | 1 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Anti-epileptic Agent [EPC] | 2 |
| 1 | Complement Inhibitor [EPC] | 2 |
| 2 | Loop Diuretic [EPC] | 2 |
| 3 | Mood Stabilizer [EPC] | 2 |
| 4 | Potassium Channel Blocker [EPC] | 2 |
| 5 | 5-alpha Reductase Inhibitor [EPC] | 1 |
| 6 | Antihypoglycemic Agent [EPC] | 1 |
| 7 | Atypical Antipsychotic [EPC] | 1 |
| 8 | Azole Antifungal [EPC] | 1 |
| 9 | Benzodiazepine [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antihypoglycemic Agent [EPC] | 1 | 0.0002 |
| 1 | Phosphodiesterase 3 Inhibitor [EPC] | 1 | 0.0002 |
| 2 | Parenteral Iron Replacement [EPC] | 1 | 0.0001 |
| 3 | Stimulant Laxative [EPC] | 1 | 0.0001 |
| 4 | Typical Antipsychotic [EPC] | 1 | 0.0000 |
| 5 | Complement Inhibitor [EPC] | 2 | 0.0000 |
| 6 | Iron Chelator [EPC] | 1 | 0.0000 |
| 7 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 8 | Potassium Channel Blocker [EPC] | 2 | 0.0000 |
| 9 | Pyrimidine Synthesis Inhibitor [EPC] | 1 | 0.0000 |